A61K38/06 - page 4 - CPC Classification Index

#901

20130244925

2013-09-19

Molecules mimicking an autoantibody idiotype and compositions containing same

#902

20130231278

2013-09-05

Methods of treatment using water-soluble tryptophan-containing peptides obtained by the hydrolysis of hens eggs lysozyme

#903

20130230544

2013-09-05

Immunostimulatory method

#904

20130217617

2013-08-22

Pyruvamide compounds as inhibitors of dust mite group 1 peptidase allergen and their use

#905

20130210732

2013-08-15

Agent for reducing risk in onset of disease ascribable to non-dipper circadian rhythm of blood pressure

#906

20130195894

2013-08-01

Detection and treatment of autoimmune disorders

#907

20130172239

2013-07-04

SOLID COMPOSITIONS

#908

20130165392

2013-06-27

Hepatocyte growth factor mimics as therapeutic agents

#909

20130149281

2013-06-13

ORGANIC COMPOUNDS AND THEIR USES

#910

20130142754

2013-06-06

Hepatitis C virus inhibitors

#911

20130130968

2013-05-23

COMPOUNDS FOR ENZYME INHIBITION

#912

20130129621

2013-05-23

Integrin receptor antagonists and their methods of use

#913

20130123167

2013-05-16

Drug inhibiting the progression of atherosclerosis, preventive drug, blood cholesterol-lowering drug, functional food, and specific health food

#914

20130115190

2013-05-09

Hepatitis C virus inhibitors

#915

20130102558

2013-04-25

Methods for treating HCV

#916

20130102557

2013-04-25

Methods for treating HCV

#917

20130102527

2013-04-25

Inhibitors of the trypsin-like site of the proteasome and methods of use thereof

#918

20130065872

2013-03-14

Synthesis of syrbactin proteasome inhibitors

#919

20130065834

2013-03-14

MODULATORS OF PROTEASOME ACTIVITY

#920

20130064905

2013-03-14

Method for enhancing the growth and fullness of hair

#921

20130059854

2013-03-07

Dosage form for insertion into the mouth

#922

20130059784

2013-03-07

Combination therapies using cyclosporine and aromatic cationic peptides

#923

20130052280

2013-02-28

USE OF THEBROMINE FOR LOWERING CENTRAL BLOOD PRESSURE

#924

20130040901

2013-02-14

MITOCHONDRIAL-TARGETED ANTIOXIDANTS PROTECT AGAINST MECHANICAL VENTILATION-INDUCED DIAPHRAGM DYSFUNCTION AND SKELETAL MUSCLE ATROPHY

#925

20130035295

2013-02-07

Use of peptide epoxyketones for metastasis suppression

#926

20130034519

2013-02-07

Peptidomimetic sulfamide compounds and antiviral uses thereof

#927

20130022573

2013-01-24

Macrocyclic inhibitors of flaviviridae viruses

#928

20130022572

2013-01-24

Peptidomimetic sulfamide compounds and antiviral uses thereof

#929

20130018172

2013-01-17

Metal Abstraction Peptide and Uses Thereof

#930

20130017229

2013-01-17

Active scaffolds for on-demand drug and cell delivery

#931

20130017150

2013-01-17

Methods for prevention and treatment of acute renal injury

#932

20120330019

2012-12-27

Hepatitis C virus inhibitors

#933

20120328666

2012-12-27

Oral delivery of peptide pharmaceutical compositions

#934

20120322722

2012-12-20

Pyruvamide compounds as inhibitors of dust mite group 1 peptidase allergen and their use

#935

20120315279

2012-12-13

Method for inhibiting platelet derived growth factor signaling with C3aR or C5aR antibodies

#936

20120309938

2012-12-06

Hemiasterlin derivatives and uses thereof in the treatment of cancer

#937

20120302505

2012-11-29

CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERY

#938

20120295853

2012-11-22

Neuronal pain pathway

#939

20120277176

2012-11-01

Protein Arginine Deiminase inhibitors as novel therapeutics for rheumatoid arthritis and cancer

#940

20120277167

2012-11-01

Oral formulations of glycyl-2-methylprolyl-glutamate

#941

20120270811

2012-10-25

Conformations of divergent peptides with mineral binding affinity

#942

20120269769

2012-10-25

Hepatitis C Inhibitor Compounds

#943

20120264678

2012-10-18

METHODS OF USING [3.2.0] HETEROCYCLIC COMPOUNDS AND ANALOGS THEREOF FOR TREATING INFECTIOUS DISEASES

#944

20120251581

2012-10-04

Compound and methods for its production

#945

20120232248

2012-09-13

THERAPEUTIC AGENT FOR PULMONARY SMALL CELL CARCINOMA

#946

20120231998

2012-09-13

Organic compounds and their uses

#947

20120219537

2012-08-30

Method for repairing DNA damage in keratinocytes

#948

20120216302

2012-08-23

Methods and assays for treating subjects with SHANK3 deletion, mutation or reduced expression

#949

20120208748

2012-08-16

Peptide compositions and methods for treating patients

#950

20120208747

2012-08-16

Peptide for augmenting and expression of BDNF and pharmaceutical composition for prevention and treatment of neurodegenerative diseases including Alzheimer's disease or Parkinson's disease, comprising the same

#951

20120207712

2012-08-16

Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin

#952

20120202970

2012-08-09

Fragment ligated inhibitors selective for the polo box domain of PLK1

#953

20120196789

2012-08-02

Peptide based peroxidase inhibitors and methods of using same

#954

20120190614

2012-07-26

HCV protease inhibitors and uses thereof

#955

20120165271

2012-06-28

Methods of treating retinitis pigmentosa

#956

20120149638

2012-06-14

METHODS FOR PREVENTING OR TREATING INSULIN RESISTANCE

#957

20120142615

2012-06-07

Methods related to the treatment of neurodegenerative and inflammatory conditions

#958

20120135921

2012-05-31

Tripeptide boronic acid or boronic ester, preparative method and use thereof

#959

20120130350

2012-05-24

DETECTION AND TREATMENT OF AUTOIMMUNE DISORDERS

#960

20120115786

2012-05-10

AGENT FOR REDUCING RISK IN ONSET OF DISEASE ASCRIBABLE TO NON-DIPPER CIRCADIAN RHYTHM OF BLOOD PRESSURE

#961

20120114751

2012-05-10

PHARMACEUTICAL COMPOSITION FOR TREATING HCV INFECTIONS

#962

20120108520

2012-05-03

Method of treating tumors

#963

20120100086

2012-04-26

Proteasome-activating lightening peptidic hydrolyzates and compositions containing them

#964

20120094919

2012-04-19

USE OF TRIPEPTIDES

#965

20120088740

2012-04-12

Co-crystals and pharmaceutical compositions comprising the same

#966

20120083483

2012-04-05

Inhibitors of hepatitis C virus replication

#967

20120077735

2012-03-29

PROPHYLACTIC AGENT FOR RENAL FAILURE

#968

20120064020

2012-03-15

NOVEL COMPOSITION

#969

20120060834

2012-03-15

Pharmaceutical preparation to be administered into respiratory organs for treating or preventing inflammatory respiratory diseases, and method for treating or preventing such diseases

#970

20120058947

2012-03-08

Prophylactic agent for heart failure

#971

20120052094

2012-03-01

Agonists of neurotrophin receptors and their use as medicaments

#972

20120045502

2012-02-23

Antagonists of MUC1

#973

20120045462

2012-02-23

Inflammation inhibiting compounds

#974

20120040895

2012-02-16

PEPTIDE AVAILABILITY

#975

20120034187

2012-02-09

Hepatitis C Inhibitor Compounds

#976

20120028902

2012-02-02

PEPTIDE AVAILABILITY

#977

20120021029

2012-01-26

PEPTIDES USED IN THE TREATMENT AND/OR CARE OF THE SKIN AND/OR HAIR AND THEIR USE IN COSMETIC OR PHARMACEUTICAL COMPOSITIONS

#978

20120014887

2012-01-19

Compounds, in particular peptides, compositions comprising them and cosmetic and dermo-pharmaceutical uses

#979

20120010159

2012-01-12

COMBINATION THERAPIES WITH COX-2 INHIBITORS AND TREPROSTINIL

#980

20120004263

2012-01-05

Compounds for the treatment of pathologies associated with aging and degenerative disorders

#981

20120003300

2012-01-05

Composition Comprising Vascular Endothelial Growth Factor (VEGF) for the Treatment of Hair Loss

#982

20110312897

2011-12-22

CATHEPSIN L PROTEOLYTICALLY PROCESSES HISTONE H3 DURING MOUSE EMBRYONIC STEM CELL DIFFERENTIATION

#983

20110311482

2011-12-22

Hepatitis C virus inhibitors

#984

20110301199

2011-12-08

COMPOSITIONS AND METHODS FOR TREATING MYELODYSPLASTIC SYNDROME

#985

20110301198

2011-12-08

Compositions and methods for treating myelodysplastic syndrome

#986

20110301102

2011-12-08

COMPOSITIONS AND METHODS FOR TREATING MYELODYSPLASTIC SYNDROME

#987

20110288163

2011-11-24

Methods of treating cachexia with macrocyclic modulators of the ghrelin receptor

#988

20110275562

2011-11-10

Inhibition of gliadin peptides

#989

20110263817

2011-10-27

METAL-BINDING COMPOUNDS AND USES THEREFOR

#990

20110263516

2011-10-27

VASODILATOR

#991

20110263506

2011-10-27

Peptides having an ACE inhibiting effect

#992

20110250284

2011-10-13

Nanoparticles for Use as Synthetic Platelets and Therapeutic Agent Delivery Vehicles

#993

20110250176

2011-10-13

Combinations of hepatitis C virus inhibitors

#994

20110245149

2011-10-06

Methods to prevent and treat diseases

#995

20110237525

2011-09-29

Method of ameliorating oxidative stress and supplementing the diet

#996

20110236453

2011-09-29

Treatment of biofilms

#997

20110206790

2011-08-25

Antimicrobial Foamable Soaps

#998

20110206723

2011-08-25

Use of plant cell membrane for the treatment of obesity

#999

20110195043

2011-08-11

Dimeric Smac mimetics

#1000

20110189166

2011-08-04

METHODS OF TREATING HEMORHEOLOGIC ABNORMALITIES IN MAMMALS

#1001

20110177047

2011-07-21

Methods and compositions for preventing or treating ophthalmic conditions

#1002

20110177030

2011-07-21

Hepatitis C inhibitor compounds

#1003

20110166073

2011-07-07

Anti-hypertensive agent

#1004

20110165143

2011-07-07

MODULATION OF CASPASES AND THERAPEUTICAL APPLICATIONS

#1005

20110165064

2011-07-07

Methods and compositions related to clot-binding compounds

#1006

20110160140

2011-06-30

Composition for improving brain function and method for improving brain function

#1007

20110160133

2011-06-30

Method for inhibiting inflammation and pre-inflammatory cytokine/chemokine expression using a ghrelin analogue

#1008

20110159004

2011-06-30

Methods and Compositions for Preserving the Viability of Photoreceptor Cells

#1009

20110152341

2011-06-23

CLEAVAGE OF B-AMYLOID PRECURSOR PROTEIN

#1010

20110142830

2011-06-16

Modulation of the TrpV: Vps10p receptor system for the treatment of pain

#1011

20110135730

2011-06-09

Oral formulations of glycyl-2-methylprolyl-glutamate

#1012

20110124663

2011-05-26

Substituted dioxopiperidines and dioxopyrrolidines as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction

#1013

20110112033

2011-05-12

Cognitive enhancement and cognitive therapy using glycyl-L-2-methylprolyl-L-glutamic acid

#1014

20110104146

2011-05-05

Method of inhibiting platelet aggregation and clot formation

#1015

20110098229

2011-04-28

Compositions and methods for treating dermatological conditions

#1016

20110092440

2011-04-21

METHOD OF REGULATING CELL GROWTH USING A PROTEASOME INHIBITOR

#1017

20110086803

2011-04-14

PEPTIDES CONTAINING TRYPTOPHAN

#1018

20110086060

2011-04-14

NOVEL COMPOSITIONS AND THEIR USE

#1019

20110082086

2011-04-07

MEDICAMENT FOR USE IN CONNECTION WITH CARTILAGE IMPAIRMENT

#1020

20110077191

2011-03-31

Inhibitors of mammalian tight junction opening

#1021

20110071075

2011-03-24

PROMOTER FOR BICARBONATE SECRETION IN GASTROINTESTINAL TRACT

#1022

20110064657

2011-03-17

Labeled inhibitors of prostate specific membrane antigen (PSMA), biological evaluation, and use as imaging agents

#1023

20110045589

2011-02-24

Methods of controlling proliferation and differentiation of stem and progenitor cells

#1024

20110045046

2011-02-24

Glycopeptides and methods of making and using them

#1025

20110039935

2011-02-17

USE OF PHARMACOLOGICALLY ACTIVE CHEMICAL COMPOUNDS

#1026

20110039766

2011-02-17

METHODS FOR PREVENTING OR TREATING METABOLIC SYNDROME

#1027

20110027274

2011-02-03

Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof

#1028

20110020272

2011-01-27

COMBINATION THERAPY FOR TREATING HEPATITIS VIRAL INFECTION

#1029

20110015139

2011-01-20

Histidine related compounds for identifying and blocking amyloid beta ion channels

#1030

20110009411

2011-01-13

THERAPEUTIC COMPOSITIONS AND THE USE THEREOF

#1031

20110009332

2011-01-13

Therapeutic Treatment Of Wounds

#1032

20100331243

2010-12-30

Organic compounds and their uses

#1033

20100323968

2010-12-23

Process of inhibiting cell death in injured cartilage

#1034

20100317571

2010-12-16

Methods for reducing CD36 expression

#1035

20100317570

2010-12-16

Composition and Method for the Treatment of Diseases Affected by a Peptide Receptor

#1036

20100311690

2010-12-09

BOROPEPTIDE INHIBITORS OF ENTEROPEPTIDASE AND THEIR USES IN TREATMENT OF OBESITY, OVERWEIGHT AND/OR DISEASES ASSOCIATED WITH AN ABNORMAL FAT METABOLISM

#1037

20100303937

2010-12-02

NOVEL COMPOSITION TO INCREASE TESTOSTERONE LEVELS

#1038

20100298205

2010-11-25

METHODS AND COMPOSITIONS FOR THE TREATMENT OF CONDITIONS RELATED TO GASTRIC ACID SECRETION

#1039

20100297139

2010-11-25

Methods and compositions for the treatment of proteinuric diseases

#1040

20100279944

2010-11-04

SUPPRESSION AND TREATMENT OF NEUROPATHIC PAIN

#1041

20100279941

2010-11-04

CD36 MODULATION AND USES THEREOF

#1042

20100267621

2010-10-21

Antimicrobial compounds and formulations

#1043

20100260709

2010-10-14

Derivatised proline containing peptide compounds as protease inhibitors

#1044

20100247693

2010-09-30

COSMETIC FORMULATION TO TREAT ROSACEA TELANGIECTASIA

#1045

20100240977

2010-09-23

METHOD FOR MEASURING THE RESPONSE OF A TISSUE TO AN ELECTROMAGNETIC FIELD

#1046

20100240591

2010-09-23

TPP II INHIBITORS FOR USE IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISEASES AND TRANSPLANT REJECTION

#1047

20100240581

2010-09-23

SELECTIVE PROTEASOME INHIBITORS FOR TREATING DIABETES

#1048

20100233249

2010-09-16

CONTRACEPTIVE METHODS AND COMPOSITIONS RELATED TO PROTEASOMAL INTERFERENCE

#1049

20100215726

2010-08-26

Compositions for Diminishing the Appearance of Wrinkles

#1050

20100210564

2010-08-19

DRUG OR FOOD CONTAINING A PEPTIDE

#1051

20100204155

2010-08-12

USE OF THE PEPTIDE SFLLR-OH AND MURAMYL DIPEPTIDE AS THERAPEUTIC AGENTS

#1052

20100204140

2010-08-12

USE OF A PEPTIDE AS A THERAPEUTIC AGENT

#1053

20100204137

2010-08-12

THE USE OF SUBSTANCES FOR THE TREATMENT OF LOSS OF EYESIGHT IN HUMANS WITH GLAUCOMA AND OTHER DEGENERATIVE EYE DISEASES

#1054

20100197585

2010-08-05

USE OF A RGD-PEPTIDE AND/OR PARATHYROID HORMONE (1-34) AS ANTI-HIV AGENT

#1055

20100184708

2010-07-22

USE OF GLY-PRO-GLU-OH (GPE) AS A THERAPEUTIC AGENT

#1056

20100183718

2010-07-22

COMPOSITIONS AND TREATMENT OF HEART DEFICIENCY IN NON-HUMAN ANIMALS

#1057

20100168046

2010-07-01

METHODS OF USING [3.2.0] HETEROCYCLIC COMPOUNDS AND ANALOGS THEREOF FOR TREATING INFECTIOUS DISEASES

#1058

20100168038

2010-07-01

USE OF COMPOUNDS IN COMBINATION WITH GAMMA-IRRADIATION FOR THE TREATMENT OF CANCER

#1059

20100166859

2010-07-01

NOVEL NUTRACEUTICAL COMPOSITIONS AND USE THEREOF

#1060

20100166808

2010-07-01

Method of Facilitating Intracellular Uptake or Transcellular Transport of Cargo Using Nanocarriers Containing Optimal Surface Densities of Integrin-Specific Ligands

#1061

20100144647

2010-06-10

Dual acting prodrugs

#1062

20100144644

2010-06-10

Metal-binding compounds and uses therefor

#1063

20100143322

2010-06-10

USE OF INHIBITORS OF N-METHYL TRANSFERASES FOR THE THERAPY OF PARKINSON'S DISEASE

#1064

20100136094

2010-06-03

Systems for modulating inflammation

#1065

20100135983

2010-06-03

Anti-inflammatory compositions and methods

#1066

20100135966

2010-06-03

AGENTS FOR TREATING FLAVIVIRIDAE INFECTIONS

#1067

20100129343

2010-05-27

Use Of A Compound For Enhancing The Expression Of Membrane Proteins On The Cell Surface

#1068

20100112050

2010-05-06

Dosage form for insertion into the mouth

#1069

20100105914

2010-04-29

CASPASE INHIBITORS AND USES THEREOF

#1070

20100099628

2010-04-22

CARBOHYDRATE-BASED PERITONEAL DIALYSIS FLUID COMPRISING GLUTAMINE RESIDUE

#1071

20100069294

2010-03-18

HCV protease inhibitors and uses thereof

#1072

20100068182

2010-03-18

Combination therapy for treating HCV infection

#1073

20100063095

2010-03-11

Hemiasterlin derivatives and uses thereof in the treatment of cancer

#1074

20100047270

2010-02-25

USE OF PLANT CELL MEMBRANE FOR THE TREATMENT OF OBESITY

#1075

20100041674

2010-02-18

HCV protease inhibitors and uses thereof

#1076

20100035793

2010-02-11

Modulators

#1077

20100028317

2010-02-04

Skin repair compositions comprising circadian gene activators and a synergistic combination of 1 gene activators

#1078

20100022748

2010-01-28

PROPHYLACTIC AGENT FOR RENAL FAILURE

#1079

20100022747

2010-01-28

PROPHYLACTIC AGENT FOR HEART FAILURE

#1080

20100021401

2010-01-28

METHOD FOR TREATING SKIN

#1081

20100015115

2010-01-21

Compound preparation for quickly reducing oxidative stress and preparation of the same

#1082

20090325888

2009-12-31

Peptides having a health benefit and compositions comprising them

#1083

20090325885

2009-12-31

Composition for acceleration of type I collagen production

#1084

20090319020

2009-12-24

DEVICES, SYSTEMS, AND METHODS FOR PROMOTING ENDOTHELIALIZATION

#1085

20090312427

2009-12-17

Medicament for Use in Connection With Cartilage Impairment

#1086

20090312270

2009-12-17

Peptides having an ace inhibiting effect

#1087

20090312260

2009-12-17

DRUG THERAPY FOR CELIAC SPRUE

#1088

20090306085

2009-12-10

HCV protease inhibitors and uses thereof

#1089

20090304869

2009-12-10

Peptides Having an Ace Inhibiting Effect

#1090

20090286741

2009-11-19

Methods for improving the structure and function of arterioles

#1091

20090275512

2009-11-05

COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR DISEASE AND MYOCARDIAL INFARCTION WITH DIPEPTIDYL PEPTIDASE INHIBITORS OR B TYPE NATRIURETIC PEPTIDE ANALOGUES RESISTANT TO PROLYL-SPECIFIC DIPEPTIDYL DEGRADATION

#1092

20090274656

2009-11-05

Hepatitis C virus inhibitors

#1093

20090264369

2009-10-22

Methods for reducing CD36 expression

#1094

20090257952

2009-10-15

Engineered integrin binding peptides

#1095

20090253641

2009-10-08

Method for reducing the risk, lessening the symptom, or delaying the onset of insulin resistance by administering SS-31

#1096

20090239808

2009-09-24

Calcium receptor activator

#1097

20090239807

2009-09-24

Methods and kits for diagnosing and/or assessing severity and treating gaucher disease

#1098

20090238895

2009-09-24

NUTRITIONAL AND/OR PHARMACEUTICAL PREPARATION FOR USE IN PROPHYLAXIS AND TREATMENT OF DISTURBANCES IN MICROELEMENTS ABSORPTION FROM THE ALIMENTARY CANAL

#1099

20090234097

2009-09-17

VASODILATOR

#1100

20090232827

2009-09-17

Compositions and methods of use of compounds to increase cancer patient survival time

#1101

20090227521

2009-09-10

USE OF COMPOUNDS IN THE TREATMENT OF ISCHEMIA AND NEURODEGENERATION

#1102

20090227520

2009-09-10

Treatment methods using peptides related to amyloid precursor protein

#1103

20090221713

2009-09-03

ApoE mimetic agents

#1104

20090221514

2009-09-03

Methods for prevention and treatment of acute renal injury

#1105

20090221513

2009-09-03

Treatment of Neurodegenerative Disorders

#1106

20090220481

2009-09-03

Method and compositions for treating skin

#1107

20090220463

2009-09-03

Pharmaceutical Composition For Treating Vascular-Related Diseases Comprising Peptide

#1108

20090215702

2009-08-27

UV-induced dermatitis inhibitor and atopic dermatitis inhibitor

#1109

20090214518

2009-08-27

Methods and compositions for treating solid tumors and enhancing tumor vaccines

#1110

20090203698

2009-08-13

Compounds for enzyme inhibition

#1111

20090203628

2009-08-13

Composition, Method And Kit For Treating Skin Disorders And Improving Skin Condition

#1112

20090203621

2009-08-13

Tripeptides that down regulate the activity of plasma membrane transporters including sodium-D-glucose cotransporter SgIt1

#1113

20090203605

2009-08-13

Methods For Treating A Condition Characterized By Dysfunction In Protein Homeostasis

#1114

20090203591

2009-08-13

Methods and compositions for emergency contraception using endothelin receptor antagonists

#1115

20090186827

2009-07-23

Process of inhibiting cell death in injured cartilage

#1116

20090175961

2009-07-09

Dietary supplement compositions

#1117

20090175824

2009-07-09

Peptides for the treatment of HCV infections

#1118

20090170757

2009-07-02

Methods of using macrocyclic modulators of the ghrelin receptor

#1119

20090163425

2009-06-25

Peptide inhibiting angiotensin converting enzyme

#1120

20090149394

2009-06-11

Use of effectors of glutaminyl and glutamate cyclases

#1121

20090131331

2009-05-21

Novel Nutraceutical Compositions

#1122

20090130121

2009-05-21

Synthetic Peptide Copolymers for Treatment and Prevention of Cardiovascular Disorders

#1123

20090111758

2009-04-30

USE OF THERAPEUTICALLY USEFUL PEPTIDES

#1124

20090110667

2009-04-30

Detection and treatment of autoimmune disorders

#1125

20090104151

2009-04-23

Smac mimetic dimers and trimers useful as anti-cancer agents

#1126

20090099098

2009-04-16

Peptide, pharmaceutical composition, and a method of treating microcirculation disorders

#1127

20090093482

2009-04-09

THERAPEUTIC COMPOSITIONS AND METHODS

#1128

20090082252

2009-03-26

Compositions containing peptides with non-natural amino acids and methods of use

#1129

20090076176

2009-03-19

Prodrugs activated by plasmin and their use in cancer chemotherapy

#1130

20090074865

2009-03-19

Oral formulations of glycyl-2-methylprolyl-glutamate

#1131

20090062213

2009-03-05

Small molecule inhibitors of PDZ interactions

#1132

20090062201

2009-03-05

INTEGRIN BINDING MOTIF CONTAINING PEPTIDES AND METHODS OF TREATING SKELETAL DISEASES

#1133

20090048302

2009-02-19

Methods and compositions for the treatment of conditions related to gastric acid secretion

#1134

20090042809

2009-02-12

Blood Pressure Lowering Protein Hydrolysates

#1135

20090042791

2009-02-12

INTEGRIN BINDING MOTIF CONTAINING PEPTIDES AND METHODS OF TREATING SKELETAL DISEASES

#1136

20090012141

2009-01-08

Composition and method for making oligo-benzamide compounds

#1137

20090005320

2009-01-01

COMPOSITIONS COMPRISING AMINO ACID BICARBONATE AND METHODS OF USE THEREOF

#1138

20090004158

2009-01-01

Methods of controlling proliferation and differentiation of stem and progenitor cells

#1139

20080317822

2008-12-25

Methods for Delivery of Nanosome Encapsulated Agents

#1140

20080317734

2008-12-25

NUTRACEUTICAL COMPOSITIONS AND METHODS WITH BIOLOGICALLY ACTIVE INGREDIENTS

#1141

20080312147

2008-12-18

Compositions and Methods for the Regulation of Hair Growth

#1142

20080306009

2008-12-11

Immunoregulatory compositions

#1143

20080300193

2008-12-04

Composition and method for the treatment of diseases affected by a peptide receptor

#1144

20080280968

2008-11-13

METHODS OF USING [3.2.0] HETEROCYCLIC COMPOUNDS AND ANALOGS THEREOF FOR TREATING INFECTIOUS DISEASES

#1145

20080274961

2008-11-06

Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of sarcoidosis

#1146

20080255248

2008-10-16

Prodrug compounds with isoleucine

#1147

20080255055

2008-10-16

Use of Derivatives of Dipeptides for the Manufacture of of a Medicament for the Treamtent of Microbial Infections

#1148

20080249021

2008-10-09

Biologically active peptides and their use for repairing injured nerves

#1149

20080227725

2008-09-18

Cosmetic or pharmaceutical composition comprising peptides, uses and treatment processes

#1150

20080221038

2008-09-11

Compounds for control of appetite

#1151

20080200400

2008-08-21

Dermatological compositions including oligopeptides for increasing skin sensitivity and neuronal perception

#1152

20080194491

2008-08-14

Methods of Diagnosing, Preventing, and Treating Early Onset of Pulmonary Hypertension

#1153

20080194490

2008-08-14

AT4 RECEPTOR LIGANDS AS ANGIOGENIC, ANTI-ANGIOGENIC, AND ANTI-TUMOR AGENTS

#1154

20080194489

2008-08-14

Treatment of iatrogenic disease

#1155

20080194485

2008-08-14

Detection and Use of Prolylcarboxypeptidase

#1156

20080194467

2008-08-14

CANCER TREATMENT METHODS USING CADHERIN ANTAGONISTS IN COMBINATION WITH ANTICANCER AGENTS

#1157

20080176806

2008-07-24

Therapeutic uses of tri-, tetra-, penta-, and polypeptides

#1158

20080166428

2008-07-10

Sensitization to another anticancer therapy and/or amelioration of a side effect of another anticancer therapy by treatment with a GST-activated anticancer compound

#1159

20080161241

2008-07-03

Inhibitor of cardiac tachyarrhythmias

#1160

20080153759

2008-06-26

Treatment methods using polypeptides related to amyloid precursor protein

#1161

20080153755

2008-06-26

Treatment of tumors

#1162

20080139458

2008-06-12

Methods of Treatment For Injured or Diseased Joints

#1163

20080138416

2008-06-12

METHOD AND SYSTEMS FOR USING BIOPOLYMER-BASED BEADS AND HYDROGELS

#1164

20080125395

2008-05-29

Compositions and methods for the treatment of skin

#1165

20080125354

2008-05-29

SELECTIVE INHIBITION OF MATRIX METALLOPROTEINASES

#1166

20080095754

2008-04-24

OPHTHALMIC COMPOSITIONS COMPRISING DIGLYCINE

#1167

20080076720

2008-03-27

Personal care compositions having kinetin or zeatin

#1168

20080076719

2008-03-27

IMMUNOREGULATORY COMPOSITIONS

#1169

20080069801

2008-03-20

Methods and apparatus for using polymer-based beads and hydrogels for cardiac applications

#1170

20080058264

2008-03-06

Amino-acid containing composition for inhibiting accumulation of fat

#1171

20080051434

2008-02-28

Hemiasterlin derivatives and uses thereof in the treatment of cancer

#1172

20080045495

2008-02-21

Treatment of Patients with Cystic Disease by Alteration of Fibrocystin Proteolysis

#1173

20080045444

2008-02-21

COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR DISEASE AND MYOCARDIAL INFARCTION WITH DIPEPTIDYL PEPTIDASE INHIBITORS OR B TYPE NATRIURETIC PEPTIDE ANALOGUES RESISTANT TO PROLYL-SPECIFIC DIPEPTIDYL DEGRADATION

#1174

20080038208

2008-02-14

Pharmaceutical/cosmetic compositions comprising the lysine-d-proline-valine tripeptide

#1175

20080038199

2008-02-14

Methods related to the treatment of neurodegenerative and inflammatory conditions

#1176

20080027139

2008-01-31

Use of Alpha-Ketoglutarate and Related Compounds

#1177

20080008694

2008-01-10

METHODS TO PREVENT AND TREAT DISEASES

#1178

20080004223

2008-01-03

DERMATOLOGICAL USES OF THE TRIPEPTIDE MELANOCYTE STIMULATING INHIBITORY FACTOR (MIF)

#1179

20070298009

2007-12-27

Effects of glycyl-2 methyl prolyl glutamate on neurodegeneration

#1180

20070287756

2007-12-13

Methods and compositions for preserving the viability of photoreceptor cells

#1181

20070286842

2007-12-13

Organic compounds and their uses

#1182

20070274951

2007-11-29

Combinations comprising HCV protease inhibitor(s) and HCV polymerase inhibitor(s), and methods of treatment related thereto

#1183

20070269847

2007-11-22

METHODS, PHARMACEUTICAL FORMULATIONS AND KITS FOR IDENTIFICATION OF SUBJECTS AT RISK FOR CANCER

#1184

20070269527

2007-11-22

Therapeutic agents for low HDL-cholesterolemia

#1185

20070265194

2007-11-15

Agents for the treatment of viral infections

#1186

20070264715

2007-11-15

Proteins Involved in Signal Transduction

#1187

20070249541

2007-10-25

Combined use of enzyme inhibitors and of pharmaceutical compositions thereof

#1188

20070243166

2007-10-18

Hepatitis C inhibitor compounds

#1189

20070237735

2007-10-11

Anti-aging composition, kit and method of use

#1190

20070232568

2007-10-04

Carbohydrate Composition and Its Use for the Preparation of a Medicament for Treating or Preventing Pulmonary Inflammation or Acute Respiration Distress Syndrome

#1191

20070232527

2007-10-04

Medicaments and methods combining a HCV protease inhibitor and an AKR competitor

#1192

20070224167

2007-09-27

Novel HCV inhibitor combinations and methods

#1193

20070224165

2007-09-27

Neuroprotective Effects of Gly-Pro-Glu Following Intravenous Infusion

#1194

20070218043

2007-09-20

Use of a compound for enhancing the expression of membrane proteins on the cell surface

#1195

20070212683

2007-09-13

Co-crystals and pharmaceutical compositions comprising the same

#1196

20070207944

2007-09-06

Blood Pressure Lowering Oligopeptides

#1197

20070207144

2007-09-06

Ubiquitin/proteasome inhibitors for the treatment of spinal muscular atrophy

#1198

20070203055

2007-08-30

Compounds and compositions for prevention of overdose of oxycodone

#1199

20070172444

2007-07-26

Hair tonics and method of screening the same

#1200

20070166288

2007-07-19

Formulation to improve survival of transplanted cells